Summary
Updated Aug 30, 2026
Shlomo Nachman is Director of AtriCure, Inc. (ATRC). 1 SEC Form 4 filing on record, dated 20 May 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Shlomo Nachman has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Shlomo Nachman files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Sven Wehrwein - $1.32M of ATRC open-market activity in the last 12 months
- Justin J. Noznesky - $541K of ATRC open-market activity in the last 12 months
- Vinayak Doraiswamy - $523K of ATRC open-market activity in the last 12 months
- Karl S. Dahlquist - $458K of ATRC open-market activity in the last 12 months
- Maggie Yuen - $242K of ATRC open-market activity in the last 12 months
- Karen Prange - $224K of ATRC open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Shlomo Nachman?
Shlomo Nachman is a corporate insider, tracked as Director of AtriCure, Inc. (ATRC). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Shlomo Nachman last file a Form 4?
The only primary Form 4 on record is dated 20 May 2026.
Where can I see all of Shlomo Nachman's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Shlomo Nachman and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial